Q3 2023 Holdings
Filed 2023-11-14 | 196 holdings | $6.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $448.1M | 911,530 | 7.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $418.8M | 9,233,700 | 6.7% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $348.7M | 1,002,735 | 5.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $290.6M | 2,583,550 | 4.7% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $242.3M | 828,999 | 3.9% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $165.1M | 3,170,250 | 2.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $158.4M | 894,345 | 2.6% |
| Moderna Inc(MRNA) | COM | 60770K107 | $154.5M | 1,495,325 | 2.5% |
| Abbott Labs(ABT) | COM | 002824100 | $151.2M | 1,560,968 | 2.4% |
| Incyte Corp(INCY) | COM | 45337C102 | $143.9M | 2,491,450 | 2.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $139.7M | 2,646,295 | 2.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $130.7M | 4,721,500 | 2.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $130.2M | 258,205 | 2.1% |
| Stryker Corporation(SYK) | COM | 863667101 | $130.0M | 475,613 | 2.1% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $126.4M | 2,252,851 | 2.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $100.1M | 3,677,115 | 1.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $99.3M | 4,013,500 | 1.6% |
| Humana Inc(HUM) | COM | 444859102 | $82.7M | 170,046 | 1.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $79.9M | 3,162,735 | 1.3% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $78.7M | 304,230 | 1.3% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $76.4M | 1,119,819 | 1.2% |
| Elevance Health Inc(ELV) | COM | 036752103 | $75.7M | 173,887 | 1.2% |
| Option Care Health Inc(OPCH) | COM NEW | 68404L201 | $73.9M | 2,284,293 | 1.2% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $72.3M | 3,513,351 | 1.2% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $71.0M | 1,025,457 | 1.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $64.0M | 685,733 | 1.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $60.5M | 7,245,188 | 1.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $57.4M | 237,252 | 0.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $52.3M | 1,900,000 | 0.8% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $52.0M | 158,438 | 0.8% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $51.9M | 2,375,925 | 0.8% |
| Align Technology Inc(ALGN) | COM | 016255101 | $51.0M | 166,886 | 0.8% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $50.6M | 254,279 | 0.8% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $50.3M | 641,492 | 0.8% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $50.0M | 114,441 | 0.8% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $48.2M | 134,330 | 0.8% |
| Accolade Inc(ACCDEUR) | COM | 00437E102 | $47.9M | 4,527,923 | 0.8% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $45.7M | 9,803,313 | 0.7% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $45.6M | 224,100 | 0.7% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $44.9M | 229,342 | 0.7% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $44.5M | 2,142,769 | 0.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $44.1M | 631,487 | 0.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $43.8M | 81,541 | 0.7% |
| Insulet Corp(PODD) | COM | 45784P101 | $42.2M | 264,359 | 0.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $41.7M | 2,125,200 | 0.7% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $41.1M | 4,885,000 | 0.7% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $40.8M | 898,400 | 0.7% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $38.3M | 155,643 | 0.6% |
| The Cigna Group(CI) | COM | 125523100 | $35.9M | 125,502 | 0.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $34.5M | 266,226 | 0.6% |